|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 8443 |
FusionGeneSummary for CREBBP_TP53TG3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CREBBP_TP53TG3 | Fusion gene ID: 8443 | Hgene | Tgene | Gene symbol | CREBBP | TP53TG3 | Gene ID | 1387 | 24150 |
| Gene name | CREB binding protein | TP53 target 3 | |
| Synonyms | CBP|KAT3A|RSTS|RSTS1 | P53TG3|TP53TG3A|TP53TG3E|TP53TG3F | |
| Cytomap | 16p13.3 | 16p11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | CREB-binding protein | TP53-target gene 3 proteinTP53-inducible gene 3 proteinp53 target gene 3 | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | Q92793 | Q9ULZ0 | |
| Ensembl transtripts involved in fusion gene | ENST00000262367, ENST00000382070, | ENST00000398682, ENST00000569420, ENST00000568854, ENST00000398680, | |
| Fusion gene scores | * DoF score | 25 X 18 X 14=6300 | 2 X 2 X 2=8 |
| # samples | 34 | 2 | |
| ** MAII score | log2(34/6300*10)=-4.21174517713694 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: CREBBP [Title/Abstract] AND TP53TG3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CREBBP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 21539536 |
| Hgene | CREBBP | GO:0006355 | regulation of transcription, DNA-templated | 12169688 |
| Hgene | CREBBP | GO:0006473 | protein acetylation | 15273251|24939902 |
| Hgene | CREBBP | GO:0016573 | histone acetylation | 11742995 |
| Hgene | CREBBP | GO:0018076 | N-terminal peptidyl-lysine acetylation | 12435739 |
| Hgene | CREBBP | GO:0034644 | cellular response to UV | 24939902 |
| Hgene | CREBBP | GO:0045893 | positive regulation of transcription, DNA-templated | 11742995 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LUAD | TCGA-69-8255-01A | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000262367 | ENST00000398682 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-3UTR | ENST00000262367 | ENST00000569420 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-5UTR | ENST00000262367 | ENST00000568854 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-intron | ENST00000262367 | ENST00000398680 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| In-frame | ENST00000382070 | ENST00000398682 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-3UTR | ENST00000382070 | ENST00000569420 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-5UTR | ENST00000382070 | ENST00000568854 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
| 5CDS-intron | ENST00000382070 | ENST00000398680 | CREBBP | chr16 | 3900298 | - | TP53TG3 | chr16 | 32685885 | - |
Top |
FusionProtFeatures for CREBBP_TP53TG3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CREBBP | TP53TG3 |
| Acetylates histones, giving a specific tag fortranscriptional activation. Also acetylates non-histone proteins,like NCOA3 and FOXO1. Binds specifically to phosphorylated CREBand enhances its transcriptional activity toward cAMP-responsivegenes. Acts as a coactivator of ALX1. Acts as a circadiantranscriptional coactivator which enhances the activity of thecircadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers. Acetylates PCNA; acetylation promotesremoval of chromatin-bound PCNA and its degradation duringnucleotide excision repair (NER) (PubMed:24939902).{ECO:0000269|PubMed:11154691, ECO:0000269|PubMed:12738767,ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221,ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:9707565}. | May play a significant role in p53/TP53-mediatingsignaling pathway. {ECO:0000269|PubMed:10534768}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1061_1064 | 266 | 2443 | Compositional bias | Note=Poly-Glu |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1199_1487 | 266 | 2443 | Compositional bias | Note=Cys/His-rich |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1555_1562 | 266 | 2443 | Compositional bias | Note=Poly-Glu |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1943_1948 | 266 | 2443 | Compositional bias | Note=Poly-Pro |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1967_1970 | 266 | 2443 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 2081_2085 | 266 | 2443 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 2199_2216 | 266 | 2443 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 2245_2248 | 266 | 2443 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 2297_2300 | 266 | 2443 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1061_1064 | 266 | 2405 | Compositional bias | Note=Poly-Glu |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1199_1487 | 266 | 2405 | Compositional bias | Note=Cys/His-rich |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1555_1562 | 266 | 2405 | Compositional bias | Note=Poly-Glu |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1943_1948 | 266 | 2405 | Compositional bias | Note=Poly-Pro |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1967_1970 | 266 | 2405 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 2081_2085 | 266 | 2405 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 2199_2216 | 266 | 2405 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 2245_2248 | 266 | 2405 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 2297_2300 | 266 | 2405 | Compositional bias | Note=Poly-Gln |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1103_1175 | 266 | 2443 | Domain | Bromo |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1323_1700 | 266 | 2443 | Domain | CBP/p300-type HAT |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 587_666 | 266 | 2443 | Domain | KIX |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1103_1175 | 266 | 2405 | Domain | Bromo |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1323_1700 | 266 | 2405 | Domain | CBP/p300-type HAT |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 587_666 | 266 | 2405 | Domain | KIX |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1434_1436 | 266 | 2443 | Region | Acetyl-CoA binding |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1446_1447 | 266 | 2443 | Region | Acetyl-CoA binding |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1434_1436 | 266 | 2405 | Region | Acetyl-CoA binding |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1446_1447 | 266 | 2405 | Region | Acetyl-CoA binding |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1701_1744 | 266 | 2443 | Zinc finger | ZZ-type |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1765_1846 | 266 | 2443 | Zinc finger | TAZ-type 2 |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 347_433 | 266 | 2443 | Zinc finger | TAZ-type 1 |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1701_1744 | 266 | 2405 | Zinc finger | ZZ-type |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1765_1846 | 266 | 2405 | Zinc finger | TAZ-type 2 |
| Hgene | >CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 347_433 | 266 | 2405 | Zinc finger | TAZ-type 1 |
Top |
FusionGeneSequence for CREBBP_TP53TG3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_CREBBP_ENST00000262367_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_270aa MAENLLDGPPNPKRAKLSSPGFSANDSTDFGSLFDLENDLPDELIPNGGELGLLNSGNLVPDAASKHKQLSELLRGGSGSSINPGIGNVS ASSPVQQGLGGQAQGQPNSANMASLSAMGKSPLSQGDSSAPSLPKQAASTSGPTPAASQALNPQAQKQVGLATSSPATSQTGPGICMNAN FNQTHPGLLNSNSGHSLINQASQGQAQVMNGSLGAAGRGRGAGMPYPTPAMQGASSSVLAETLTQVSPQMTGHAGLNTAQAGGMAKFFRL >In-frame_CREBBP_ENST00000382070_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_270aa MAENLLDGPPNPKRAKLSSPGFSANDSTDFGSLFDLENDLPDELIPNGGELGLLNSGNLVPDAASKHKQLSELLRGGSGSSINPGIGNVS ASSPVQQGLGGQAQGQPNSANMASLSAMGKSPLSQGDSSAPSLPKQAASTSGPTPAASQALNPQAQKQVGLATSSPATSQTGPGICMNAN FNQTHPGLLNSNSGHSLINQASQGQAQVMNGSLGAAGRGRGAGMPYPTPAMQGASSSVLAETLTQVSPQMTGHAGLNTAQAGGMAKFFRL |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_CREBBP_ENST00000262367_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_811nt ATGGCTGAGAACTTGCTGGACGGACCGCCCAACCCCAAAAGAGCCAAACTCAGCTCGCCCGGTTTCTCGGCGAATGACAGCACAGATTTT GGATCATTGTTTGACTTGGAAAATGATCTTCCTGATGAGCTGATACCCAATGGAGGAGAATTAGGCCTTTTAAACAGTGGGAACCTTGTT CCAGATGCTGCTTCCAAACATAAACAACTGTCGGAGCTTCTACGAGGAGGCAGCGGCTCTAGTATCAACCCAGGAATAGGAAATGTGAGC GCCAGCAGCCCCGTGCAGCAGGGCCTGGGTGGCCAGGCTCAAGGGCAGCCGAACAGTGCTAACATGGCCAGCCTCAGTGCCATGGGCAAG AGCCCTCTGAGCCAGGGAGATTCTTCAGCCCCCAGCCTGCCTAAACAGGCAGCCAGCACCTCTGGGCCCACCCCCGCTGCCTCCCAAGCA CTGAATCCGCAAGCACAAAAGCAAGTGGGGCTGGCGACTAGCAGCCCTGCCACGTCACAGACTGGACCTGGTATCTGCATGAATGCTAAC TTTAACCAGACCCACCCAGGCCTCCTCAATAGTAACTCTGGCCATAGCTTAATTAATCAGGCTTCACAAGGGCAGGCGCAAGTCATGAAT GGATCTCTTGGGGCTGCTGGCAGAGGAAGGGGAGCTGGAATGCCGTACCCTACTCCAGCCATGCAGGGCGCCTCGAGCAGCGTGCTGGCT GAGACCCTAACGCAGGTTTCCCCGCAAATGACTGGTCACGCGGGACTGAACACCGCACAGGCAGGAGGCATGGCCAAGTTTTTCAGGTTA >In-frame_CREBBP_ENST00000382070_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_811nt ATGGCTGAGAACTTGCTGGACGGACCGCCCAACCCCAAAAGAGCCAAACTCAGCTCGCCCGGTTTCTCGGCGAATGACAGCACAGATTTT GGATCATTGTTTGACTTGGAAAATGATCTTCCTGATGAGCTGATACCCAATGGAGGAGAATTAGGCCTTTTAAACAGTGGGAACCTTGTT CCAGATGCTGCTTCCAAACATAAACAACTGTCGGAGCTTCTACGAGGAGGCAGCGGCTCTAGTATCAACCCAGGAATAGGAAATGTGAGC GCCAGCAGCCCCGTGCAGCAGGGCCTGGGTGGCCAGGCTCAAGGGCAGCCGAACAGTGCTAACATGGCCAGCCTCAGTGCCATGGGCAAG AGCCCTCTGAGCCAGGGAGATTCTTCAGCCCCCAGCCTGCCTAAACAGGCAGCCAGCACCTCTGGGCCCACCCCCGCTGCCTCCCAAGCA CTGAATCCGCAAGCACAAAAGCAAGTGGGGCTGGCGACTAGCAGCCCTGCCACGTCACAGACTGGACCTGGTATCTGCATGAATGCTAAC TTTAACCAGACCCACCCAGGCCTCCTCAATAGTAACTCTGGCCATAGCTTAATTAATCAGGCTTCACAAGGGCAGGCGCAAGTCATGAAT GGATCTCTTGGGGCTGCTGGCAGAGGAAGGGGAGCTGGAATGCCGTACCCTACTCCAGCCATGCAGGGCGCCTCGAGCAGCGTGCTGGCT GAGACCCTAACGCAGGTTTCCCCGCAAATGACTGGTCACGCGGGACTGAACACCGCACAGGCAGGAGGCATGGCCAAGTTTTTCAGGTTA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_CREBBP_ENST00000262367_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_2642nt TTCTTTTTTTTTTAATTGAGGAATCAACAGCCGCCATCTTGTCGCGGACCCGACCGGGGCTTCGAGCGCGATCTACTCGGCCCCGCCGGT CCCGGGCCCCACAACCGCCCGCGCACCCCGCTCCGCCCGGCCGGCCCGCTCCGCCCGGCCCTCGGCGCCCGCCCCGGCGGCCCCGCTCGC CTCTCGGCTCGGCCTCCCGGAGCCCGGCGGCGGCGGCGGCGGCAGCGGCGGCGGCGGCGGCGGAACGGGGGGTGGGGGGGCCGCGGCGGC GGCGGCGACCCCGCTCGGCGCATTGTTTTTCCTCACGGCGGCGGCGGCGGCGGGCCGCGGGCCGGGAGCGGAGCCCGGAGCCCCCTCGTC GTCGGGCCGCGAGCGAATTCATTAAGTGGGGCGCGGGGGGGGAGCGAGGCGGCGGCGGCGGCGGCACCATGTTCTCGGGGACTGCCTGAG CCGCCCGGCCGGGCGCCGTCGCTGCCAGCCGGGCCCGGGGGGGCGGCCGGGCCGCCGGGGCGCCCCCACCGCGGAGTGTCGCGCTCGGGA GGCGGGCAGGGGATGAGGGGGCCGCGGCCGGCGGCGGCGGCGGCGGCCGGGGGCGGGCGGTGAGCGCTGCGGGGCGCTGTTGCTGTGGCT GAGATTTGGCCGCCGCCTCCCCCACCCGGCCTGCGCCCTCCCTCTCCCTCGGCGCCCGCCCGCCCGCTCGCGGCCCGCGCTCGCTCCTCT CCCTCGCAGCCGGCAGGGCCCCCGACCCCCGTCCGGGCCCTCGCCGGCCCGGCCGCCCGTGCCCGGGGCTGTTTTCGCGAGCAGGTGAAA ATGGCTGAGAACTTGCTGGACGGACCGCCCAACCCCAAAAGAGCCAAACTCAGCTCGCCCGGTTTCTCGGCGAATGACAGCACAGATTTT GGATCATTGTTTGACTTGGAAAATGATCTTCCTGATGAGCTGATACCCAATGGAGGAGAATTAGGCCTTTTAAACAGTGGGAACCTTGTT CCAGATGCTGCTTCCAAACATAAACAACTGTCGGAGCTTCTACGAGGAGGCAGCGGCTCTAGTATCAACCCAGGAATAGGAAATGTGAGC GCCAGCAGCCCCGTGCAGCAGGGCCTGGGTGGCCAGGCTCAAGGGCAGCCGAACAGTGCTAACATGGCCAGCCTCAGTGCCATGGGCAAG AGCCCTCTGAGCCAGGGAGATTCTTCAGCCCCCAGCCTGCCTAAACAGGCAGCCAGCACCTCTGGGCCCACCCCCGCTGCCTCCCAAGCA CTGAATCCGCAAGCACAAAAGCAAGTGGGGCTGGCGACTAGCAGCCCTGCCACGTCACAGACTGGACCTGGTATCTGCATGAATGCTAAC TTTAACCAGACCCACCCAGGCCTCCTCAATAGTAACTCTGGCCATAGCTTAATTAATCAGGCTTCACAAGGGCAGGCGCAAGTCATGAAT GGATCTCTTGGGGCTGCTGGCAGAGGAAGGGGAGCTGGAATGCCGTACCCTACTCCAGCCATGCAGGGCGCCTCGAGCAGCGTGCTGGCT GAGACCCTAACGCAGGTTTCCCCGCAAATGACTGGTCACGCGGGACTGAACACCGCACAGGCAGGAGGCATGGCCAAGTTTTTCAGGTTA AGTACTGCACGACTACTCGCTTCTGAAACTGATAGACACTGCCTCAGCTCCGTGCAGGGCAGACGCACAAGAGCAGAATCTCCGTGGGAC ATCTCTCTGGAGCATCAATATTACTGCAGTATTTGGAAGAAACAAATTTAAATAAGTTCTAAGGTGAAGAATGGAACATTTAAGACAAGT CTGGAAAGTCATCTGCCTTTAATAACTGTCGTTTGTCCTTAACGTCAGACTTTCTCCAAGACCAAAACTCTAAGAACTTATTTCCATTCT TACAAATAGTAAAAATGATAAATCATATCAAGTCAATTGAAAGTCCTGCCTGCTGCTTTCCTAAATTGCAATATGGCCTTGGTATGGTTT TATTTGTACTTTTGTGGGGGATTCGTGGATCTTTAGATTAAAAAAAAAAAAATAGGTTTTTGAACAATTTTTGCAAGTTTGCAGCTGTTA GTTATTGATTTATTTTTCCAACCCATCTAATTCTTCTGTCTCTCTCCTCTCCTCAGGCTCAATAATTCCATGGGTCTCTAAGGCTGTGTT TATTTTCTTTAAATTTTGTTGATTTACTTTTATACTCCATTTGATTTTTTCTATCTCTCACCTTTTCTCAGACTCAGTCATCCCACAGGT CTGTAAGGCTCTGTTCATTTTCTTTAAACTTCTTTTTTTTTTCCTCTCCTCAGATTGGATAAATTATATTGCTATGTCTCTGTTTCTGAA CTATAGAAAAGCTCAAAATTATTATTTTTATTTCTCATTTTTTATATGGCTATTTTTTCTCTGCTGATGTTTCACATCTATTCATTTATG AGAATATTTTCCTTTGCCCTCATGAGCGTGTTTATAATAGCTGCCTTCAAATTCTTGTCTGCCGTTTACATCTTGGACATCTTGGAGATG GCTACTGCCTGCTTTTTATCTTGTGTATTTATTACATTTTCACGTGTCTTCACGCATCCCTTGAATTGGAAATTGTGCCCTGGAGACTGT >In-frame_CREBBP_ENST00000382070_chr16_3900298_-_TP53TG3_ENST00000398682_chr16_32685885_-_2036nt CTGCGGGGCGCTGTTGCTGTGGCTGAGATTTGGCCGCCGCCTCCCCCACCCGGCCTGCGCCCTCCCTCTCCCTCGGCGCCCGCCCGCCCG CTCGCGGCCCGCGCTCGCTCCTCTCCCTCGCAGCCGGCAGGGCCCCCGACCCCCGTCCGGGCCCTCGCCGGCCCGGCCGCCCGTGCCCGG GGCTGTTTTCGCGAGCAGGTGAAAATGGCTGAGAACTTGCTGGACGGACCGCCCAACCCCAAAAGAGCCAAACTCAGCTCGCCCGGTTTC TCGGCGAATGACAGCACAGATTTTGGATCATTGTTTGACTTGGAAAATGATCTTCCTGATGAGCTGATACCCAATGGAGGAGAATTAGGC CTTTTAAACAGTGGGAACCTTGTTCCAGATGCTGCTTCCAAACATAAACAACTGTCGGAGCTTCTACGAGGAGGCAGCGGCTCTAGTATC AACCCAGGAATAGGAAATGTGAGCGCCAGCAGCCCCGTGCAGCAGGGCCTGGGTGGCCAGGCTCAAGGGCAGCCGAACAGTGCTAACATG GCCAGCCTCAGTGCCATGGGCAAGAGCCCTCTGAGCCAGGGAGATTCTTCAGCCCCCAGCCTGCCTAAACAGGCAGCCAGCACCTCTGGG CCCACCCCCGCTGCCTCCCAAGCACTGAATCCGCAAGCACAAAAGCAAGTGGGGCTGGCGACTAGCAGCCCTGCCACGTCACAGACTGGA CCTGGTATCTGCATGAATGCTAACTTTAACCAGACCCACCCAGGCCTCCTCAATAGTAACTCTGGCCATAGCTTAATTAATCAGGCTTCA CAAGGGCAGGCGCAAGTCATGAATGGATCTCTTGGGGCTGCTGGCAGAGGAAGGGGAGCTGGAATGCCGTACCCTACTCCAGCCATGCAG GGCGCCTCGAGCAGCGTGCTGGCTGAGACCCTAACGCAGGTTTCCCCGCAAATGACTGGTCACGCGGGACTGAACACCGCACAGGCAGGA GGCATGGCCAAGTTTTTCAGGTTAAGTACTGCACGACTACTCGCTTCTGAAACTGATAGACACTGCCTCAGCTCCGTGCAGGGCAGACGC ACAAGAGCAGAATCTCCGTGGGACATCTCTCTGGAGCATCAATATTACTGCAGTATTTGGAAGAAACAAATTTAAATAAGTTCTAAGGTG AAGAATGGAACATTTAAGACAAGTCTGGAAAGTCATCTGCCTTTAATAACTGTCGTTTGTCCTTAACGTCAGACTTTCTCCAAGACCAAA ACTCTAAGAACTTATTTCCATTCTTACAAATAGTAAAAATGATAAATCATATCAAGTCAATTGAAAGTCCTGCCTGCTGCTTTCCTAAAT TGCAATATGGCCTTGGTATGGTTTTATTTGTACTTTTGTGGGGGATTCGTGGATCTTTAGATTAAAAAAAAAAAAATAGGTTTTTGAACA ATTTTTGCAAGTTTGCAGCTGTTAGTTATTGATTTATTTTTCCAACCCATCTAATTCTTCTGTCTCTCTCCTCTCCTCAGGCTCAATAAT TCCATGGGTCTCTAAGGCTGTGTTTATTTTCTTTAAATTTTGTTGATTTACTTTTATACTCCATTTGATTTTTTCTATCTCTCACCTTTT CTCAGACTCAGTCATCCCACAGGTCTGTAAGGCTCTGTTCATTTTCTTTAAACTTCTTTTTTTTTTCCTCTCCTCAGATTGGATAAATTA TATTGCTATGTCTCTGTTTCTGAACTATAGAAAAGCTCAAAATTATTATTTTTATTTCTCATTTTTTATATGGCTATTTTTTCTCTGCTG ATGTTTCACATCTATTCATTTATGAGAATATTTTCCTTTGCCCTCATGAGCGTGTTTATAATAGCTGCCTTCAAATTCTTGTCTGCCGTT TACATCTTGGACATCTTGGAGATGGCTACTGCCTGCTTTTTATCTTGTGTATTTATTACATTTTCACGTGTCTTCACGCATCCCTTGAAT |
Top |
FusionGenePPI for CREBBP_TP53TG3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CREBBP | EGR1, HNF4A, NFE2L2, TDG, AIRE, NCOA6, BRCA1, CREB1, AR, N4BP2, CTNNB1, RELA, SS18L1, PIAS3, NPAS2, EBF1, E2F1, E2F3, KLF5, PML, SRF, TP53, KLF1, ING1, SMAD1, CSNK2A1, CUX1, ATF1, EWSR1, NR3C1, HNF1A, HOXB7, MSX1, HTT, TCF3, MGMT, KMT2A, MYOD1, ATF2, JUN, MECOM, GLI3, DDX5, PTMA, MYB, FOXO1, FOXO4, RPS6KA3, CITED1, STAT1, STAT6, MAF, PELP1, RPS6KA2, RBBP4, RBBP7, ONECUT1, SERTAD1, SREBF1, SREBF2, NFATC2, TRIP4, HIF1A, NFE2, STAT2, SMARCA4, NCOA1, ESR1, MAML1, MYBL2, KAT2B, GTF2B, CITED2, IRF3, NUP98, TRERF1, TGS1, KLF4, STAT3, NEUROG1, HIPK2, KHDRBS1, GATA1, PHOX2A, SNIP1, NFATC4, KLF13, XRCC6, FOS, POLR2A, SMARCB1, CCNC, CDK8, MED21, NKX2-1, NCOA3, PPARG, ATF4, RPA2, PPARGC1A, HIST3H3, HIST4H4, EP300, ANAPC7, ANAPC5, CDC16, ANAPC2, CDH1, CDC20, REL, DDX17, GCM1, MAP3K5, MAPK10, MKNK1, APC, PAPOLA, CPSF6, TBX21, NCOR1, NCOR2, CARM1, ESR2, YY1, MYC, PLAGL1, MIER1, HDAC1, SP1, SP3, HDAC3, VDR, DAXX, CEBPB, CEBPD, PARP1, PTMS, ATXN3, CTBP1, HIST1H3A, MTF1, SETD1A, MYBL1, NLK, SMAD3, DEK, FGFR1, RPS6KA1, CDKN1A, SND1, NCOA2, KAT6A, SRCAP, TAF6L, ETS1, ETS2, RUNX2, MAFK, TCF12, HDAC2, HOXB6, KPNA2, KPNA6, NR5A1, HMGA1, FOXO3, HIST1H4A, HES6, RUVBL1, FOSL1, FOSB, JUNB, FOXM1, HMGB1, HMGB2, POU1F1, IRF1, SMAD2, RARA, SH3GL1, BCL6, GRIP1, KLF8, NFYB, TRIM28, POT1, WDR5, IRF5, AKT1, CDC27, ATF3, ATG3, MDM2, HOXB2, HOXB3, HOXB9, HOXD12, HOXD13, HOXD10, HOXD4, HOXB4, HOXA10, HOXA9, PBX1, SMARCA2, MYH9, MSH6, MSH2, ZBTB2, ZNF639, ACTA2, CSNK2A2, TP73, PRLR, MED25, PTOV1, IFNAR2, IRF9, TBP, RPS6KA5, IRF7, KAT5, PYGO2, HBP1, TACC2, NPAT, CCNE1, ELAVL1, KDM3B, PSMC5, MDC1, LYN, HCK, SRC, ZCCHC12, RAD23A, RUNX1, CHUK, IKBKB, IKBKG, HIST2H2BE, LIG4, TLR2, EPAS1, MTDH, MEIS1, LDLR, DYRK1B, DYRK1A, CDK2, EID1, COPS2, PSME3, WRN, KLF2, UBE2D1, CREBBP, UBE2I, MAPK3, FHL1, HIST1H2BB, EID3, POU2F3, ELK1, MAPK1, TFDP1, CREM, ZEB1, CRTC1, MAML2, CENPJ, HSF1, FHL2, CDH2, PHOX2B, DDIT3, XAF1, BMI1, CCND3, TXNDC11, CCNA2, C3orf62, PPP1R13L, BRMS1, PCNA, UBE2S, TLE3, MUS81, PTTG1, MED23, SNAI1, TFAP2B, SMAD4, NR3C2, ARNTL, CLOCK, SUMO1, NFATC1, CPSF4, RFPL3, CTGF, NFYA, KIAA0430, HELZ, NISCH, SOWAHA, PCGF3, EIF4ENIF1, PAN2, JUP, HSPA8, LAMP2, TRIM25 | TP53TG3 | ELAVL1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1162_1180 | 266 | 2443 | ASF1A |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1162_1180 | 266 | 2405 | ASF1A |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1433_1435 | 266 | 2443 | histone |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1433_1435 | 266 | 2405 | histone |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1124_1170 | 266 | 2443 | histone |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1124_1170 | 266 | 2405 | histone |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 227_410 | 266 | 2443 | SRCAP |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 227_410 | 266 | 2405 | SRCAP |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000262367 | - | 2 | 31 | 1460_1891 | 266 | 2443 | TRERF1 |
| Hgene | CREBBP | chr16:3900298 | chr16:32685885 | ENST00000382070 | - | 2 | 30 | 1460_1891 | 266 | 2405 | TRERF1 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CREBBP_TP53TG3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CREBBP_TP53TG3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CREBBP | C0035934 | Rubinstein-Taybi Syndrome | 3 | CTD_human;ORPHANET;UNIPROT |
| Hgene | CREBBP | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| Hgene | CREBBP | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Hgene | CREBBP | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | CREBBP | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Hgene | CREBBP | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| Hgene | CREBBP | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | CREBBP | C0011573 | Endogenous depression | 1 | PSYGENET |
| Hgene | CREBBP | C0024301 | Lymphoma, Follicular | 1 | CTD_human |
| Hgene | CREBBP | C0036341 | Schizophrenia | 1 | PSYGENET |
| Hgene | CREBBP | C0036920 | Sezary Syndrome | 1 | CTD_human |
| Hgene | CREBBP | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
| Hgene | CREBBP | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Hgene | CREBBP | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Hgene | CREBBP | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|